Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research
Jonàs Juan‐Mateu, Olatz Villate, Décio L. Eizirik
European Journal of Endocrinology (2016) Vol. 174, Iss. 5, pp. R225-R238
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Opportunities and obstacles for deep learning in biology and medicine
Travers Ching, Daniel Himmelstein, Brett K. Beaulieu‐Jones, et al.
Journal of The Royal Society Interface (2018) Vol. 15, Iss. 141, pp. 20170387-20170387
Open Access | Times Cited: 1842
Molecular mechanisms of ROS production and oxidative stress in diabetes
Philip Newsholme, Vinícius Fernandes Cruzat, Kevin N. Keane, et al.
Biochemical Journal (2016) Vol. 473, Iss. 24, pp. 4527-4550
Open Access | Times Cited: 753
Opportunities and obstacles for deep learning in biology and medicine
Travers Ching, Daniel Himmelstein, Brett K. Beaulieu‐Jones, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2017)
Open Access | Times Cited: 138
Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
Megan Stevens, Sebastian Oltean
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 113
The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis
Giulia Cardamone, Elvezia Maria Paraboschi, Valeria Rimoldi, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 3, pp. 576-576
Open Access | Times Cited: 90
Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance
Eddie A. James, Massimo Pietropaolo, Mark J. Mamula
Diabetes (2018) Vol. 67, Iss. 6, pp. 1035-1042
Open Access | Times Cited: 83
Splicing in immune cells—mechanistic insights and emerging topics
Annalisa Schaub, Elke Glasmacher
International Immunology (2017) Vol. 29, Iss. 4, pp. 173-181
Open Access | Times Cited: 64
Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival
Jonàs Juan‐Mateu, Tatiana Helena Rech, Olatz Villate, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 8, pp. 3466-3480
Open Access | Times Cited: 63
Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis
Giulia Cardamone, Elvezia Maria Paraboschi, Giulia Soldà, et al.
Human Molecular Genetics (2018) Vol. 28, Iss. 9, pp. 1414-1428
Closed Access | Times Cited: 59
Deep Learning for Genomics: From Early Neural Nets to Modern Large Language Models
Tianwei Yue, Yuanxin Wang, Longxiang Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15858-15858
Open Access | Times Cited: 21
Emerging roles of RNA‐binding proteins in diabetes and their therapeutic potential in diabetic complications
Curtis A. Nutter, Muge N. Kuyumcu‐Martinez
Wiley Interdisciplinary Reviews - RNA (2017) Vol. 9, Iss. 2
Open Access | Times Cited: 57
SRp55 Regulates a Splicing Network That Controls Human Pancreatic β-Cell Function and Survival
Jonàs Juan‐Mateu, Maria Inês Alvelos, Jean-Valéry Turatsinze, et al.
Diabetes (2017) Vol. 67, Iss. 3, pp. 423-436
Open Access | Times Cited: 50
Abnormalities in alternative splicing in diabetes: therapeutic targets
Zodwa Dlamini, Fortunate Mokoena, Rodney Hull
Journal of Molecular Endocrinology (2017) Vol. 59, Iss. 2, pp. R93-R107
Open Access | Times Cited: 49
A deep learning approach to identify gene targets of a therapeutic for human splicing disorders
Dadi Gao, Elisabetta Morini, Monica Salani, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 36
Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review
Jamie L. Felton, Kurt Griffin, Richard A. Oram, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 15
Transcriptome sequencing of gingival biopsies from chronic periodontitis patients reveals novel gene expression and splicing patterns
Yong‐Gun Kim, Min-Jung Kim, Ji Hyun Kang, et al.
Human Genomics (2016) Vol. 10, Iss. 1
Open Access | Times Cited: 42
Disease-specific biases in alternative splicing and tissue-specific dysregulation revealed by multitissue profiling of lymphocyte gene expression in type 1 diabetes
Jeremy R. B. Newman, Ana Conesa, Matthew Mika, et al.
Genome Research (2017) Vol. 27, Iss. 11, pp. 1807-1815
Open Access | Times Cited: 35
Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide
Ava Faridi, Yunxiang Sun, Monika Mortimer, et al.
Nano Research (2019) Vol. 12, Iss. 11, pp. 2827-2834
Open Access | Times Cited: 35
When one becomes many—Alternative splicing in β‐cell function and failure
Maria Inês Alvelos, Jonàs Juan‐Mateu, Máikel L. Colli, et al.
Diabetes Obesity and Metabolism (2018) Vol. 20, Iss. S2, pp. 77-87
Open Access | Times Cited: 34
Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes: From the CORDIOPREV Study
Manuel D. Gahete, Mercedes del Río-Moreno, Antonio Camargo, et al.
EBioMedicine (2018) Vol. 37, pp. 356-365
Open Access | Times Cited: 33
Gene expression signature predicts rate of type 1 diabetes progression
Tomi Suomi, Inna Starskaia, Ubaid Ullah Kalim, et al.
EBioMedicine (2023) Vol. 92, pp. 104625-104625
Open Access | Times Cited: 9
Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions
Elvezia Maria Paraboschi, Giulia Cardamone, Giulia Soldà, et al.
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 31
Neoantigens and Microenvironment in Type 1 Diabetes: Lessons from Antitumor Immunity
Maria J.L. Kracht, Arnaud Zaldumbide, Bart O. Roep
Trends in Endocrinology and Metabolism (2016) Vol. 27, Iss. 6, pp. 353-362
Closed Access | Times Cited: 26
From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes
Décio L. Eizirik, Florian Szymczak, Maria Inês Alvelos, et al.
Diabetes (2021) Vol. 70, Iss. 9, pp. 1915-1925
Open Access | Times Cited: 19
The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells
Maria Inês Alvelos, Mirko Brüggemann, F.X. Reymond Sutandy, et al.
Life Science Alliance (2020) Vol. 4, Iss. 3, pp. e202000825-e202000825
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top